Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $13.9 million.

  • Compass Therapeutics' Change in Acquisitions & Divestments fell 5952.22% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.4 million, marking a year-over-year decrease of 3644.85%. This contributed to the annual value of $135.0 million for FY2024, which is 2600.64% down from last year.
  • According to the latest figures from Q3 2025, Compass Therapeutics' Change in Acquisitions & Divestments is $13.9 million, which was down 5952.22% from $26.8 million recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' Change in Acquisitions & Divestments ranged from a high of $59.2 million in Q1 2023 and a low of $13.9 million during Q3 2025
  • Over the past 3 years, Compass Therapeutics' median Change in Acquisitions & Divestments value was $36.4 million (recorded in 2025), while the average stood at $35.9 million.
  • Per our database at Business Quant, Compass Therapeutics' Change in Acquisitions & Divestments surged by 44.4% in 2024 and then tumbled by 5952.22% in 2025.
  • Compass Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $51.4 million in 2023, then crashed by 50.91% to $25.2 million in 2024, then plummeted by 44.8% to $13.9 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $13.9 million for Q3 2025, versus $26.8 million for Q2 2025 and $36.4 million for Q1 2025.